02.03.14
Hip fractures may one day be treated with orthobiologics, as such applications heal bones quicker than conventional methods.
"Thse most exciting thing is that everything is about to change. It's going to be exciting,"said Thomas A. "Toney"Russell, M.D., a surgical consultant and inventor at Knee Creations LLC, a West Chester, Pa.-based developer of a joint-preservation knee treatment called Subchondroplasty that uses a specialized bone void filler to heal bone defects without affecting the joint. Since its introduction in November 2010, more than 1,500 Subchondroplasty procedures have been completed.
Zimmer acquired the company's business assets last spring.
Current orthobiologics used as implant surface enhancements interfere with fracture healing, Russell said. A number of published studies indicate that orthobiologics can deliver materials and the biodegradability of the osteoconductive matrix.
Orthobiologics applications now include surface enhancements, hydroxyapatite coatings, systemic medication delivery, parathyroid hormone, bisphosphonates and biomaterials. Future options (as well as nagging current issues) for orthobiologics most likely will involve the use of new calcium phosphate cements with increased porosity, proper insertion and positioning, and implant interface, augmentation, Russell noted.
"Thse most exciting thing is that everything is about to change. It's going to be exciting,"said Thomas A. "Toney"Russell, M.D., a surgical consultant and inventor at Knee Creations LLC, a West Chester, Pa.-based developer of a joint-preservation knee treatment called Subchondroplasty that uses a specialized bone void filler to heal bone defects without affecting the joint. Since its introduction in November 2010, more than 1,500 Subchondroplasty procedures have been completed.
Zimmer acquired the company's business assets last spring.
Current orthobiologics used as implant surface enhancements interfere with fracture healing, Russell said. A number of published studies indicate that orthobiologics can deliver materials and the biodegradability of the osteoconductive matrix.
Orthobiologics applications now include surface enhancements, hydroxyapatite coatings, systemic medication delivery, parathyroid hormone, bisphosphonates and biomaterials. Future options (as well as nagging current issues) for orthobiologics most likely will involve the use of new calcium phosphate cements with increased porosity, proper insertion and positioning, and implant interface, augmentation, Russell noted.